Patent Reform Bill Moves to Senate; Biotech, University Groups Provide Measured Support | GenomeWeb

This story was originally posted on April 3.

A contentious patent reform bill that stalled in the markup phase in Senate last year is one step closer to fruition after it passed through the Senate Judiciary Committee yesterday.

The 19-member panel voted 15-4 to report the bill, a companion version of which already passed in the US House of Representatives in 2007. The legislation will now move on to be considered by the full Senate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.